Brian founded Data Sciences Intl. (DSI), the leading provider of wireless implantable sensors and systems for preclinical testing of new drugs and biomedical research. He bootstrapped DSI with highly competitive SBIR grants from the National Institutes of Health into a highly profitable business with > $40 mm revenue. He developed a domestic and international direct sales and distribution network serving 40 countries on five continents. DSI was named to the Inc. 500 list of Americaís fastest growing private companies for three consecutive years, was named SBA Exporter of the Year, and won the Tibbetts Award for commercialization of technology developed with SBIR grants. DSI also received several awards and recognition for technology innovation and creative financing strategies during Brianís tenure.
Brian co-founded Transoma Medical in 2003 to develop insertable cardiac monitoring devices for patients with chronic cardiovascular disease. Transoma gained FDA clearance and achieved a $5M run rate prior to sale of the technology to Wilson Greatbatch during the 2009 financial crisis.
Brian has about 51 patents issued and pending in medical devices, sensors, and diagnostics and is co-author of more than 25 scientific publications (792 citations, 5,315 reads, 415 total research interest on Research Gate).
Marina founded VivaQuant in 2009 to commercialize novel signal processing algorithms for highly accurate extraction of information from ECG recordings. In addition to signal processing, Marina is an expert in the development of algorithms for ultra-low-power implementation in embedded systems and has a deep understanding of statistics, cardiovascular physiology, and intellectual property portfolio development. Prior to founding VivaQuant, Marina spent five years in the cardiac rhythm management and neurostimulation divisions of Guidant (currently Boston Scientific).
Marina has about 80 issued and pending patents in the fields of signal processing and systems for monitoring ambulatory subjects and for management of patients with chronic cardiovascular disease. She has co-authored seven scientific publications.
Chris is Chief Commercialization Officer of Rhythm Express. He is a proven leader in the Cardiac monitoring field, with 30 years of experience that include several successful startups. Chris was a co-founder and President of Mednet Healthcare Technologies, a remote cardiac monitoring company that created the first IDTF that made proprietary devices and software. The Company grew to $20M in revenue under his leadership. At Medicomp, a United Therapeutics company, Chris held the position of Director of Business Development where he positioned Medicomp as an industry leader. Chris also held executive positions with Medicalgorithmics and InfoBionic where he played a key role in marketing and sales. Chris has developed an extensive network of relationships in the remote cardiac monitoring field with Industry Leaders and Healthcare Providers during his tenure in the field. His experience and passion for remote patient monitoring is evident in his pursuit of establishing Rhythm Express as a leader and creating a new Gold Standard in patient care.
JC is Director of Marketing for the Rhythm Express product line. He brings 24 years of experience in medical devices, including 18 years at Medtronic, to VivaQuant's Remote Cardiac Monitoring Systems business. John has held product management, team management, technical support, marketing, and international marketing roles at Medtronic and Transoma Medical. As a product manager, he teamed with the sales force to successfully launch more than 15 products in the Medtronic AF, Cardiac Surgery and Cardiac Rhythm Management divisions. While at Medtronic, he managed global product lines including RF ablation and diagnostic catheters, capital equipment, and delivery systems. He developed several product promotions and training modules for field sales teams and customers. He has close relationships with numerous electrophysiologists and cardiologists in the Midwest, across the nation and overseas. John holds an MBA from the University of St. Thomas.
Our team has extensive experience with the design, manufacture, and marketing of products for biomedical research, medical devices, and ambulatory diagnostics and monitoring. Specific technology expertise includes signal processing, ultra-low-power embedded systems, sensors, low-power mixed signal design, and RF telemetry.